- Biostar Pharmaceuticals (OTC:BSPM +3.5%) filed a Form 12b-25 with the SEC today reporting that it will be late filing its Q2 10-Q due to a delay in assembling the information required for the financial statements.
Biostar Pharma late with Q2 report
Recommended For You
More Trending News
About BSPM Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| BSPM | - | - |
| Biostar Pharmaceuticals, Inc. | ||